Complaints and Serious Adverse Event Reporting - Receiving, Investigating, and Reporting What Comes Back From the Market
Dietary supplement manufacturers must follow written procedures to review every product complaint, investigate those that suggest a specification failure or other Part 111 problem, and keep a record of each complaint. Separately, the responsible person named on the label must report serious adverse events to FDA on the MedWatch form within 15 business days, with a copy of the label, and must send new medical information within the same time. This map details the pathway from receipt through review, investigation, reporting, response, and record keeping.
21 CFR Part 111 Subpart O · 111.560 · 111.570 · FD&C Act Section 761